Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0628

-3.4%

12:12 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: travisnye who wrote (11889)	4/17/2013 12:08:18 PM
From: Mimbari	3 Recommendations Read Replies (1) of 13111

This stock doesn't trade in a volume high enough to put reliability into graphs. It also is a company with no income yet. So graphing the trends is mute. This is a stock, however, that goes up and down plus and minus 50cents until either big pharm's make big deals or it is bought out. SPA's and phase III's are just news and not income. Getting onto NASDQ will allow life science investors to jump in and that would raise the price. So the time line will be this: regional deal with China most likely, then a price bump, NASDQ, life science investments, global deal along with ending phase III early. This stock will stay low until big news. Now applying for BTD and receiving a positive reply will cause this all to happen in less that six months instead of another year and a half, a snowball already rolling down hill.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next